Home › Rxi Pharmaceuticals: One Undervalued Biotech That Keeps Building Its Pipeline For Future Value
 

Keywords :   


Rxi Pharmaceuticals: One Undervalued Biotech That Keeps Building Its Pipeline For Future Value

2015-05-02 15:52:22| Biotech - Topix.net

Multiple collaborations between the sd-rxRNA technology and other biotech platforms provide reduced future risk along with validation of the platform. Further positive results in scarring allow the possibility to branch into other skin areas such as Pulmonary Fibrosis and Liver Fibrosis both of which are huge markets.

Tags: future value building biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10'Rightmove is my porn' - the addiction to online property search
06.10Eastern North Pacific Tropical Weather Outlook
06.10Atlantic Tropical Weather Outlook
05.10Tropical Storm Milton Public Advisory Number 2
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 26
05.10Tropical Storm Milton Graphics
05.10Hurricane Kirk Wind Speed Probabilities Number 26
More »